[PHARMA] QoQ Cumulative Quarter Result on 31-Dec-2016 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Feb-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
31-Dec-2016 [#4]
Profit Trend
QoQ- -1.8%
YoY- -45.74%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 1,710,764 1,136,261 618,294 2,189,022 1,606,206 1,090,991 559,195 110.59%
PBT 53,198 37,927 27,777 72,017 67,948 48,025 26,538 58.91%
Tax -20,299 -8,918 -8,519 -26,158 -21,189 -13,914 -8,068 84.88%
NP 32,899 29,009 19,258 45,859 46,759 34,111 18,470 46.88%
-
NP to SH 32,023 28,443 18,923 45,599 46,435 33,374 18,379 44.74%
-
Tax Rate 38.16% 23.51% 30.67% 36.32% 31.18% 28.97% 30.40% -
Total Cost 1,677,865 1,107,252 599,036 2,143,163 1,559,447 1,056,880 540,725 112.59%
-
Net Worth 531,892 541,894 544,360 531,169 530,907 524,041 515,906 2.05%
Dividend
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Div 33,729 20,742 10,368 41,457 33,667 23,302 10,354 119.59%
Div Payout % 105.33% 72.93% 54.79% 90.92% 72.50% 69.82% 56.34% -
Equity
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Net Worth 531,892 541,894 544,360 531,169 530,907 524,041 515,906 2.05%
NOSH 259,821 259,279 259,219 259,377 258,979 258,913 258,859 0.24%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin 1.92% 2.55% 3.11% 2.09% 2.91% 3.13% 3.30% -
ROE 6.02% 5.25% 3.48% 8.58% 8.75% 6.37% 3.56% -
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
RPS 659.36 438.24 238.52 844.83 620.21 421.37 216.02 110.27%
EPS 12.34 10.97 7.30 17.60 17.93 12.89 7.10 44.50%
DPS 13.00 8.00 4.00 16.00 13.00 9.00 4.00 119.25%
NAPS 2.05 2.09 2.10 2.05 2.05 2.024 1.993 1.89%
Adjusted Per Share Value based on latest NOSH - 259,377
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
RPS 118.70 78.84 42.90 151.89 111.45 75.70 38.80 110.59%
EPS 2.22 1.97 1.31 3.16 3.22 2.32 1.28 44.30%
DPS 2.34 1.44 0.72 2.88 2.34 1.62 0.72 119.25%
NAPS 0.3691 0.376 0.3777 0.3686 0.3684 0.3636 0.358 2.05%
Price Multiplier on Financial Quarter End Date
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Date 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 -
Price 4.14 4.58 4.89 5.30 5.58 5.50 5.76 -
P/RPS 0.63 1.05 2.05 0.63 0.90 1.31 2.67 -61.78%
P/EPS 33.54 41.75 66.99 30.12 31.12 42.67 81.13 -44.47%
EY 2.98 2.40 1.49 3.32 3.21 2.34 1.23 80.29%
DY 3.14 1.75 0.82 3.02 2.33 1.64 0.69 174.35%
P/NAPS 2.02 2.19 2.33 2.59 2.72 2.72 2.89 -21.22%
Price Multiplier on Announcement Date
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Date 15/11/17 16/08/17 16/05/17 21/02/17 21/11/16 19/08/16 13/05/16 -
Price 3.82 4.19 4.72 5.12 5.70 5.62 5.60 -
P/RPS 0.58 0.96 1.98 0.61 0.92 1.33 2.59 -63.08%
P/EPS 30.95 38.20 64.66 29.09 31.79 43.60 78.87 -46.36%
EY 3.23 2.62 1.55 3.44 3.15 2.29 1.27 86.21%
DY 3.40 1.91 0.85 3.13 2.28 1.60 0.71 183.83%
P/NAPS 1.86 2.00 2.25 2.50 2.78 2.78 2.81 -24.02%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment